Improving Malaria Treatment…or, Why You Should Have Paid Attention in Geometry Class

<a href="http://www.loc.gov/pictures/item/2009615680/">Library of Congress</a>

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Prior to the 1970s, doctors weren’t aware that there was more than one type of diabetes. It was a group of Stanford researchers who made the discovery when they were analyzing a data set containing six bodily measurements from 145 patients who either had or were at risk of the disease. They applied a mathematical technique that essentially allowed them to graph the six-dimensional data set in three-dimensional space, while still preserving certain relationships between the data points. Looking at the graph, they noticed that diabetes sufferers clustered into two main groups. These groups represented what is now known as type 1 and type 2 diabetes. Drawing a distinction between the two forms of the disease undoubtedly has improved the quality of life for millions of people over the past few decades, as it has enabled the development of more specialized treatments. The moral of the story: There is a lot hidden in the data we collect. And sometimes to uncover it, we simply need to change the way we look at the information.

Take a paper published this week in BioMed Central Genetics on the detection of drug-resistant malaria strains in 264 Papua-New Guinea volunteers. You see, we don’t have a vaccine for malaria, so we have to treat it after infection. One problem this poses is that malaria can become resistant to a particular drug treatment. Figuring out which patients have resistant strains and which have strains sensitive to a particular drug is important, so that treatments can be adjusted as patients develop resistances. What the researchers in this study did was attach fluorescent beads to molecular markers associated with the drug-resistant and drug-sensitive forms of malaria. Blood samples containing the resistant strains then omitted one type of florescent “signal,” while those containing the sensitive strains omitted another. The difference between the two signals is slight, however. Traditionally, to identify which strains are resistant and which are sensitive, the researchers would just plot the signals on an xy (Cartesian) plane. Much like in the Stanford diabetes study, clusters on the graph would then emerge and be identified as containing either the drug-resistant strains or drug-sensitive strains.

Of course, the boundaries for what determines which data points fall inside and which fall outside of a cluster are not always clear. And improving those boundaries was a major goal for the researchers. In this case, their big insight came when they converted the traditional xy coordinates into polar coordinates in order to better determine those boundaries—a conversion familiar to just about every high school student: Here is a refresher on polar coordinates, and a brief overview of how the researchers used it (you can skip it if you’re not interested):

Take the point (x,y) plotted on the Cartesian plane. The point is located on the plane by moving x units horizontally from (0,0), and then moving y units vertically from (x,0). Another way to define this point would be to consider an imaginary line that connects (x,y) to (0,0). Call the length of that line r, and the angle it makes with the x-axis Θ. Now you can write (x,y) as (r, Θ). It’s the same point, only it’s now expressed as a polar coordinate. The researchers did this conversion for each point in their data set and then plotted them by treating their r-values as y-coordinates and their Θ-values as x-coordinates. This trick, explained in more detail here, allowed them to more accurately define the boundaries for drug-resistant and drug-sensitive strains.

In converting the data from Cartesian to polar coordinates (and back again) no information is gained or lost; it simply affords the researchers a different perspective on the same data set. This perspective, however, improves the researchers’ ability to draw accurate boundaries around drug-resistant and drug-sensitive strains. To give you an idea of how much it improved their results, of the 264 blood samples the researchers studied, the polar coordinate analysis allowed them to reclassify 86 that were originally classified with the traditional method—that’s just about a third of the test subjects.

Not bad for a mathematical technique most schoolchildren learn before they even have to read Wuthering Heights.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate